Achyut Healthcare Ltd Share Price

₹5.42 -0.18 (-3.21%) BSE
as updated on 10-Apr-2026 16:59 | Sector - Miscellaneous

Day Range

  • Day's Low:5.31
  • Day's High:5.70

  • 52 Week Low3.02
  • 52 Week High6.80

Achyut Healthcare Ltd's key Fundamentals

Market Cap ₹131 Cr.
P/E Ratio 238.7
TTM EPS 0
P/B Ratio 3.76
ROE 1.79
Debt to Equity 0.00
Face Value 1
BVPS 1.4
3 Year Sales Growth -9.02%

Achyut Healthcare Ltd's Share Price Returns

1 Day -3.21%
1 Week -2.30%
1 Month 0.00%
3 Months -5.60%
6 Months 0.00%
1 Years 66.80%
3 Years 78.30%
5 Years 0.00%
10 Years 0%

Financial Ratio Analysis

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

Check our DeciZen before investing

Check Stock Quality
Check Stock Valuation
Check Price Trend

Achyut Healthcare Ltd Shareholding Pattern

Promoters

(47.71%)

Institutions

(5.26%)

Non-Institutions

(47.03%)

Pledged shares as % of Promoter's holding (%)

(0.00%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Balance Sheet

(All Figures are in Crores.)

Profit And Loss

(All Figures in Cr. Adjusted EPS in Rs.)

Cash Flow

(All Figures are in Crores.)

About Achyut Healthcare Ltd

Achyut Healthcare is engaged in the trading of Pharmaceutical Products. The company has business operations in both domestic and international markets in the countries namely UAE, Kenya, and Nigeria. The company is located in Ahmedabad, Gujarat. Since incorporation, it was the company‘s vision and mission has been to remained focused towards the pharmaceutical business of trading and supplying of superior quality products to its customers based on their customizations and requirements, which has enabled it to expand its business operations globally and dive into manufacturing business on its own plants rather than outsourcing and procuring from third parties.

Business area of the company

The company is engaged in trading of Cenzure, Arpimune, Azathioprine IP, Everomimus, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Sirolimus, Tacrolimus USP, Infrared thermometer, Ascorbic Acid Coated Vitamin C, Calcium carbonate oyster, Cellulose acetate Phthalate, Chlorthalidone IP, Cross Carmalose Sod IP/USP, DI Basic Calcium Phosphate IP, DI Ethyl Phthlate, Diltiazem Hydrochloride IP, Easy Coat Fc Titanium Dioxide, Escitalopram IP, Escitalopram Oxalate, Favipiravir among many other products.

Major Events and Milestones

  • January 11, 1996: The company was incorporated as a private limited company.
  • October 21, 2002: The name of Company was changed from ‘Achyut Securities Private Limited’ to ‘Achyut Healthcare Private Limited’.
  • November 30, 2021: The Company was converted into a public limited company.
Read More Read Less
Read More Read Less

Investment related blogs

Day Range

  • Day's Low: 5.31
  • Day's High: 5.70

  • 52 Week Low3.02
  • 52 Week High6.80

Achyut Healthcare Ltd's key Fundamentals

Market Cap ₹131 Cr.
P/E Ratio 238.7
TTM EPS 0
P/B Ratio 3.76
ROE 1.79
Debt to Equity 0.00
Face Value 1
BVPS 1.4
3 Year Sales Growth -9.02%

Achyut Healthcare Ltd's Share Price Returns

1 Day -3.21%
1 Week -2.30%
1 Month 0.00%
3 Months -5.60%
6 Months 0.00%
1 Years 66.80%
3 Years 78.30%
5 Years 0.00%
10 Years 0%

Investment related blogs

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×